$64.7 Million is the total value of 72 Investment Holdings, LLC's 5 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 16.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RXDX | PROMETHEUS BIOSCIENCES INC | $52,170,000 | -25.2% | 1,848,024 | 0.0% | 80.62% | +5.6% | |
| ENTRADA THERAPEUTICS INC | $6,200,000 | +29.7% | 509,023 | 0.0% | 9.58% | +83.2% | ||
| CARIBOU BIOSCIENCES INC | $2,574,000 | -40.9% | 474,067 | 0.0% | 3.98% | -16.4% | ||
| PRAX | PRAXIS PRECISION MEDICINES I | $2,423,000 | -76.0% | 988,995 | 0.0% | 3.74% | -66.1% | |
| OMEGA THERAPEUTICS INC | $1,341,000 | -39.1% | 352,941 | 0.0% | 2.07% | -14.0% | ||
| Exit | WEWORK INCcl a | $0 | – | -29,978 | -100.0% | -0.22% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| PRAXIS PRECISION MEDICINES I | 12 | Q3 2023 | 49.0% |
| PROMETHEUS BIOSCIENCES INC | 9 | Q1 2023 | 93.9% |
| CARIBOU BIOSCIENCES INC | 9 | Q3 2023 | 15.7% |
| OMEGA THERAPEUTICS INC | 9 | Q3 2023 | 15.4% |
| ENTRADA THERAPTEUTICS INC | 8 | Q3 2023 | 60.0% |
| WEWORK INC | 2 | Q1 2022 | 0.2% |
| PALANTIR TECHNOLOGIES INC | 1 | Q4 2020 | 92.7% |
| TURNSTONE BIOLOGICS CORP | 1 | Q3 2023 | 14.5% |
View 72 Investment Holdings, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View 72 Investment Holdings, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.